Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ALDER BIOPHARMACEUTICALS INC (ALDR)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12
   10-K10-K10-K10-K10-K10-K10-K
Revenues   [+]286.63.21.30.054.718.820.1
            Revenue growth  8750.6%153.8% -100.0%191.0%-6.3% 
Cost of goods sold  0.01.60.10.00.00.00.0
Gross profit  286.61.61.20.054.718.820.1
            Gross margin  100.0%50.0%91.1% 100.0%100.0%100.0%
Selling, general and administrative   [+]47.538.126.116.712.57.77.2
Research and development  239.1252.9132.869.633.431.930.7
Equity in earnings  -0.2-0.6-0.2    
Other operating expenses  286.61.60.1    
EBITDA   [+]-284.2-288.6-156.4-85.69.5-19.8-16.8
            EBITDA margin  -99.2%-8914.3%-12254.6% 17.4%-105.5%-83.6%
Depreciation and amortization  2.63.01.70.80.70.91.0
EBIT   [+]-286.8-291.6-158.0-86.38.8-20.8-17.8
            EBIT margin  -100.1%-9007.0%-12385.8% 16.1%-110.5%-88.8%
Interest expense, net   [+]8.3-2.5-2.0-0.70.0-0.10.0
Other income (expense), net   [+]-1.30.3-0.20.20.10.1 
Pre-tax income  -296.4-288.9-156.3-85.58.9-20.6-17.8
Income taxes  0.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -331.9-288.9-156.3-85.58.9-20.6-17.8
            Net margin  -115.8%-8921.5%-12245.6% 16.3%-109.7%-88.7%
   
Basic EPS   [+]($4.87)($4.95)($3.23)($2.11)$0.43($21.14)($19.54)
Diluted EPS   [+]($4.87)($4.95)($3.23)($2.11)$0.30($21.14)($19.54)
   
Shares outstanding (basic)   [+]68.158.348.440.620.51.00.9
Shares outstanding (diluted)   [+]68.158.348.440.629.41.00.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy